Legend Biotech Corporation American Depositary Shares LEGN
$17.50
-5.61%
at last close
Market Cap$3.60 billion
P/E Ratio—
Div Yield—
Volume3.03M
52-Week Range
$16.24$37.50
Analyst Ratings
- Consensus
- Moderate Buy — 5 Buy · 4 Hold · 0 Sell (9 analysts)
- Avg. Price Target
- $44.78 (+155.9% upside)
Key Stats
- Today's Range
- $17.39 – $18.61
- 50-Day Range
- $16.86 – $24.42
- 52-Week Range
- $16.24 – $37.50
- Volume
- 3.03 million shs
- Average Volume
- 2.36 million shs
- Market Cap
- $3.60 billion
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.06%
- Days to Cover
- 1.00
About Legend Biotech Corporation American Depositary Shares
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
Related Stocks
Compare head-to-head: LEGN vs AAPL·LEGN vs NVDA·LEGN vs MSFT·LEGN vs GOOGL
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.